JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32125

Anti-Caspase-8 antibody [E6]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

3

(3 Reviews)

|

(31 Publications)

Rabbit Recombinant Monoclonal Caspase-8 antibody. Suitable for WB and reacts with Human samples. Cited in 31 publications.

View Alternative Names

MCH5, CASP8, Caspase-8, CASP-8, Apoptotic cysteine protease, Apoptotic protease Mch-5, CAP4, FADD-homologous ICE/ced-3-like protease, FADD-like ICE, ICE-like apoptotic protease 5, MORT1-associated ced-3 homolog, FLICE, MACH

5 Images
Western blot - Anti-Caspase-8 antibody [E6] (AB32125)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)

Lanes 1 and 2 : Merged signal (red and green). Green - ab32125 observed at 55 kDa. Red - loading control, ab8226, observed at 42 kDa.

ab32125 was shown to recognize Caspase-8 when Caspase-8 knockout samples were used, along with additional cross-reactive bands. Wild-type and Caspase-8 knockout samples were subjected to SDS-PAGE. ab32125 and ab8226 (loading control to beta actin) were diluted 1/3000 and 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-Caspase-8 antibody [E6] (ab32125)

Lane 1:

Wild-type HAP1 cell lysate at 20 µg

Lane 2:

Caspase-8 knockout HAP1 cell lysate at 20 µg

Predicted band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)

Lanes 1- 4 : Merged signal (red and green). Green - ab32125 observed at 55 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab32125 was shown to react with Caspase-8 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab264958 (knockout cell lysate ab256857) was used. Wild-type HeLa and CASP8 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32125 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 3000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Caspase-8 antibody [E6] (ab32125) at 1/3000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

CASP8 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human CASP8 (Caspase-8) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-casp8-caspase-8-knockout-hela-cell-line-ab264958'>ab264958</a>)

Lane 3:

Jurkat cell lysate at 20 µg

Lane 4:

SH-SY5Y cell lysate at 20 µg

Predicted band size: 55 kDa

Observed band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)
  • WB

Unknown

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)

All lanes:

Western blot - Anti-Caspase-8 antibody [E6] (ab32125) at 1/3000 dilution

All lanes:

Jurkat cell lysate

Predicted band size: 55 kDa

Observed band size: 55 kDa

false

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)

Western blot : Anti-Caspase-8 antibody [E6] ab32125 staining at 1/3000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 60 kDa in Wild-type A549 cell lysates with no signal observed at this size in CASP8 knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-Caspase-8 antibody [E6] (ab32125) at 1/3000 dilution

Lane 1:

Wild-type A549 at 20 µg

Lane 2:

Western blot - Human CASP8 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-casp8-knockout-a549-cell-line-ab286757'>ab286757</a>) at 20 µg

Lane 3:

Western blot - Human wild-type HCT116 cell line (ab288559) at 20 µg

Lane 4:

Western blot - Human CASP8 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-casp8-knockout-hct116-cell-line-ab286576'>ab286576</a>) at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 60 kDa,37 kDa

Observed band size: 60 kDa

false

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)
  • WB

Lab

Western blot - Anti-Caspase-8 antibody [E6] (AB32125)

Western blot : Rabbit Monoclonal[E6] to Caspase-8 ab32125 staining at 1/3000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 55 kDa in Wild-type HCT 116 cell lysates with no signal observed at this size in CASP8 knockout HCT 116 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-Caspase-8 antibody [E6] (ab32125) at 1/3000 dilution

Lane 1:

Wild-type HCT 116 at 20 µg

Lane 2:

Western blot - Human CASP8 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-casp8-knockout-hct116-cell-line-ab286576'>ab286576</a>) at 20 µg

Lane 3:

Wild-type HeLa at 20 µg

Lane 4:

CASP8 knockout HeLa at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 55 kDa

Observed band size: 55 kDa

false

  • Carrier free

    Anti-Caspase-8 antibody [E6] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

E6

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Epitope

ab32125 reacts with an epitope located in the N terminal region of caspase-8.

Specificity

ab32125 should recognize all splice isoforms of Caspase-8.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/3000", "WB-species-notes": "<p></p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood (PubMed : 23516580, PubMed : 35338844, PubMed : 35446120, PubMed : 8681376, PubMed : 8681377, PubMed : 8962078, PubMed : 9006941, PubMed : 9184224). Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for FAS/CD95-mediated and TNFRSF1A-induced cell death (PubMed : 23516580, PubMed : 35338844, PubMed : 35446120, PubMed : 8681376, PubMed : 8681377, PubMed : 8962078, PubMed : 9006941, PubMed : 9184224). Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 (PubMed : 16916640, PubMed : 8962078, PubMed : 9006941). Binding to the adapter molecule FADD recruits it to either receptor FAS/TNFRSF6 or TNFRSF1A (PubMed : 8681376, PubMed : 8681377). The resulting aggregate called the death-inducing signaling complex (DISC) performs CASP8 proteolytic activation (PubMed : 9184224). The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases (PubMed : 9184224). Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC (PubMed : 9184224). Also cleaves and activates BID, thereby promoting cytochrome C release from mitochrondria (By similarity). In addition to extrinsic apoptosis, also acts as a negative regulator of necroptosis : acts by cleaving RIPK1 at 'Asp-324', which is crucial to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis, necroptosis and inflammatory response (PubMed : 31827280, PubMed : 31827281). Also able to initiate pyroptosis by mediating cleavage and activation of gasdermin-C and -D (GSDMC and GSDMD, respectively) : gasdermin cleavage promotes release of the N-terminal moiety that binds to membranes and forms pores, triggering pyroptosis (PubMed : 32929201, PubMed : 34012073). Initiates pyroptosis following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a regulator of innate immunity by mediating cleavage and inactivation of N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production (By similarity). May participate in the Granzyme B (GZMB) cell death pathways (PubMed : 8755496). Cleaves PARP1 and PARP2 (PubMed : 8681376). Independent of its protease activity, promotes cell migration following phosphorylation at Tyr-380 (PubMed : 18216014, PubMed : 27109099).. Isoform 5. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.. Isoform 6. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.. Isoform 7. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex (Probable). Acts as an inhibitor of the caspase cascade (PubMed : 12010809).. Isoform 8. Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex.
See full target information CASP8

Publications (31)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1525922 PubMed40396181

2025

Vitamin D inhibits apoptosis in THP-1 cells infected with mycobacterium tuberculosis through TNF signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yusheng Yang,Jiezhong Deng,Pan Liu,Jinyue He,Jiulin Tan,Bo Yu,Yun Bai,Fei Luo,Jianzhong Xu,Zehua Zhang

Discover oncology 15:265 PubMed38967843

2024

lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoyan Yin,Haizhong Zhang,Jingmiao Wang,Yanrui Bian,Qiaojing Jia,Zhichao Yang,Chunguang Shan

Current issues in molecular biology 44:4803-4821 PubMed36286042

2022

Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics: Involvement of RIP1 and cFLIP.

Applications

Unspecified application

Species

Unspecified reactive species

Christian Holmgren,Ellen Sunström Thörnberg,Victoria Granqvist,Christer Larsson

Open life sciences 17:710-725 PubMed35859615

2022

MT-12 inhibits the proliferation of bladder cells and by enhancing autophagy through mitochondrial dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Chen,Chengxing Xia,Chunwei Ye,Feineng Liu,Yitian Ou,Ruping Yan,Haifeng Wang,Delin Yang

Cell death and differentiation 27:3037-3052 PubMed32433558

2020

Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids.

Applications

Unspecified application

Species

Unspecified reactive species

Daniela Stöhr,Jens O Schmid,Tobias B Beigl,Alexandra Mack,Daniela S Maichl,Kai Cao,Beate Budai,Gavin Fullstone,Roland E Kontermann,Thomas E Mürdter,Stephen W G Tait,Cathrin Hagenlocher,Nadine Pollak,Peter Scheurich,Markus Rehm

EMBO reports 21:e49254 PubMed32009295

2020

A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Luke M Humphreys,Jennifer P Fox,Catherine A Higgins,Joanna Majkut,Tamas Sessler,Kirsty McLaughlin,Christopher McCann,Jamie Z Roberts,Nyree T Crawford,Simon S McDade,Christopher J Scott,Timothy Harrison,Daniel B Longley

Cell death and differentiation 27:1878-1895 PubMed31831875

2019

Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica Dittmann,Tinka Haydn,Patrick Metzger,George A Ward,Melanie Boerries,Meike Vogler,Simone Fulda

Cell reports 28:3435-3449.e5 PubMed31553912

2019

Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica S Elman,Thomas K Ni,Kristen E Mengwasser,Dexter Jin,Ania Wronski,Stephen J Elledge,Charlotte Kuperwasser

Experimental and therapeutic medicine 18:3775-3782 PubMed31616509

2019

Crocetin protects against fulminant hepatic failure induced by lipopolysaccharide/D-galactosamine by decreasing apoptosis, inflammation and oxidative stress in a rat model.

Applications

Unspecified application

Species

Unspecified reactive species

Ke Gao,Faquan Liu,Xi Chen,Mengxue Chen,Qingwen Deng,Xingjian Zou,Hongxing Guo

Annals of palliative medicine 8:483-489 PubMed31431023

2019

Expression of receptor interacting protein 3 and mixed lineage kinase domain-like protein-key proteins in necroptosis is upregulated in ulcerative colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Tielong Wu,Yuanyuan Dai,Lili Xue,Yingyue Sheng,Linlin Xu,Yuzheng Xue
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com